Open AccessVaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study
Author(s) -
Felicita Heidler,
Julia Baldt,
Niklas Frahm,
Silvan Elias Langhorst,
Pegah Mashhadiakbar,
Barbara Streckenbach,
Uwe K. Zettl,
J. Richter
Publication year - 2021
Publication title -
european neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 77
eISSN - 1421-9913
pISSN - 0014-3022
DOI - 10.1159/000519582
Subject(s) - vaccination , medicine , pandemic , multiple sclerosis , disease , pediatrics , young adult , coronavirus , intensive care medicine , immunology , covid-19 , infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection represents a serious health risk, especially in chronically ill people. Multiple sclerosis (MS) is the most common chronic immune-mediated neurological disease. Vaccinations play an important role in the therapeutic MS management. This study aimed at determining MS patients' attitudes toward vaccinations and governmental measures before and during the SARS-CoV-2 pandemic, including associations with sociodemographic and clinical variables.